Literature DB >> 29627404

Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity.

Tomoyuki Okuda1, Masaki Morishita1, Kimiyasu Mizutani1, Ayumi Shibayama1, Maki Okazaki1, Hirokazu Okamoto2.   

Abstract

In the present study, a novel dry small interfering RNA (siRNA) powder for inhalation, containing polyethyleneimine (PEI) as a delivery vector, was produced by spray freeze drying (SFD). The powder had spherical and highly porous structure of approximately 10 μm in diameter with high aerosol performance for emission and lung delivery. The reconstituted siRNA/PEI complex after dissolution of the powder had almost the same physicochemical properties and in vitro gene silencing activity as the original one constituted in the sample solution before SFD, showing that the integrity of the siRNA was maintained. In in vivo studies of intratracheal administration into lung metastasis mice and healthy mice, powder with a low dose of 3 μg siRNA exhibited strong and specific gene silencing activity against tumors metastasized to the lungs, whereas it caused no significant histological changes, lactate dehydrogenase leakage, or inflammatory cytokine induction in the lungs. These results strongly indicated that inhalable dry siRNA/PEI powders can provide effective pulmonary gene silencing without severe lung injury and that SFD can be applied to the production of such powders.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aerosol gene delivery; Dry powder inhaler (DPI); Polyethyleneimine (PEI); Small interfering RNA (siRNA); Spray freeze drying (SFD)

Mesh:

Substances:

Year:  2018        PMID: 29627404     DOI: 10.1016/j.jconrel.2018.04.003

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  13 in total

1.  Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.

Authors:  Tobias W M Keil; Daniel P Feldmann; Gabriella Costabile; Qian Zhong; Sandro da Rocha; Olivia M Merkel
Journal:  Eur J Pharm Biopharm       Date:  2019-08-21       Impact factor: 5.571

2.  Spray-freeze-dried inhalable composite microparticles containing nanoparticles of combinational drugs for potential treatment of lung infections caused by Pseudomonas aeruginosa.

Authors:  Shihui Yu; Xiaohui Pu; Maizbha Uddin Ahmed; Heidi H Yu; Tarun Tejasvi Mutukuri; Jian Li; Qi Tony Zhou
Journal:  Int J Pharm       Date:  2021-10-06       Impact factor: 5.875

3.  Rational design of multistage drug delivery vehicles for pulmonary RNA interference therapy.

Authors:  A Sofia Silva; Kevin E Shopsowitz; Santiago Correa; Stephen W Morton; Erik C Dreaden; Teresa Casimiro; Ana Aguiar-Ricardo; Paula T Hammond
Journal:  Int J Pharm       Date:  2020-10-26       Impact factor: 5.875

4.  Impact of crystalline and amorphous matrices on successful spray drying of siRNA polyplexes for inhalation of nano-in-microparticles.

Authors:  Tobias Wm Keil; Christoph Zimmermann; Domizia Baldassi; Friederike Adams; Wolfgang Friess; Aditi Mehta; Olivia M Merkel
Journal:  Adv Ther (Weinh)       Date:  2021-05-07

Review 5.  T-cell targeted pulmonary siRNA delivery for the treatment of asthma.

Authors:  Tobias W M Keil; Domizia Baldassi; Olivia M Merkel
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-04-08

6.  In Vitro and In Vivo Assessment of PEGylated PEI for Anti-IL-8/CxCL-1 siRNA Delivery to the Lungs.

Authors:  Alan J Hibbitts; Joanne M Ramsey; James Barlow; Ronan MacLoughlin; Sally-Ann Cryan
Journal:  Nanomaterials (Basel)       Date:  2020-06-27       Impact factor: 5.076

Review 7.  Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects.

Authors:  You Xu; Aneesh Thakur; Yibang Zhang; Camilla Foged
Journal:  Pharmaceutics       Date:  2021-01-28       Impact factor: 6.321

Review 8.  Inhalation delivery technology for genome-editing of respiratory diseases.

Authors:  Michael Y T Chow; Rachel Yoon Kyung Chang; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2020-06-05       Impact factor: 15.470

Review 9.  Nucleic Acid-Based Therapeutics for Pulmonary Diseases.

Authors:  Jing Chen; Yue Tang; Yun Liu; Yushun Dou
Journal:  AAPS PharmSciTech       Date:  2018-10-18       Impact factor: 3.246

Review 10.  Inhaled RNA Therapy: From Promise to Reality.

Authors:  Michael Y T Chow; Yingshan Qiu; Jenny K W Lam
Journal:  Trends Pharmacol Sci       Date:  2020-09-04       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.